Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis.

Zhang, Dongyu; Bai, Bei; Xi, Yuzhi; Wang, Tengteng; Zhao, Yuqian

Zhang, Dongyu; Bai, Bei; Xi, Yuzhi; Wang, Tengteng; Zhao, Yuqian.

Afiliação

Zhang D; Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA. Electronic address: dzhang34@live.unc.edu.
Bai B; Department of Science & Technology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xi Y; Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
Wang T; Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
Zhao Y; Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China.

Gynecol Oncol ; 142(2): 368-77, 2016 Aug.

Article em En | MEDLINE | ID: mdl-27151430

Assuntos

Aspirina/administração & dosagem; Neoplasias Ovarianas/epidemiologia; Estudos de Coortes; Relação Dose-Resposta a Droga; Feminino; Humanos; Estudos Observacionais como Assunto; Neoplasias Ovarianas/prevenção & controle

Palavras-chave

Aspirin; Chemoprevention; Ovarian cancer; Systematic review and meta-analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google